Journal of Hematology & Oncology | Most Viewed

Submit a manuscript Register

Explore journal

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 1291 Accesses	Review Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin Journal of Hematology & Oncology 2011, 4:10 (22 March 2011) Abstract \| Full text \| PDF \| PubMed
	2. 629 Accesses	Review Pharmacological basis and clinical evidence of dabigatran therapy Santiago Redondo, Maria-Paz Martínez, Marta Ramajo, Jorge Navarro-Dorado, Abelardo Barez, Teresa Tejerina Journal of Hematology & Oncology 2011, 4:53 (21 December 2011) Abstract \| Full text \| PDF \| PubMed
	3. 600 Accesses	Review The effects of β-glucan on human immune and cancer cells Godfrey Chan, Wing Chan, Daniel Sze Journal of Hematology & Oncology 2009, 2:25 (10 June 2009) Abstract \| Full text \| PDF \| PubMed
	4. 467 Accesses	Review Mechanism of action of lenalidomide in hematological malignancies Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das, Amit Verma Journal of Hematology & Oncology 2009, 2:36 (12 August 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	5. 462 Accesses	Research Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function Wing Chan, Christopher Cheung, Helen Law, Yu Lau, Godfrey Chan Journal of Hematology & Oncology 2008, 1:9 (21 July 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	6. 434 Accesses	Review Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs Subhash Padhye, Aamir Ahmad, Nikhil Oswal, Fazlul H Sarkar Journal of Hematology & Oncology 2009, 2:38 (2 September 2009) Abstract \| Full text \| PDF \| PubMed
	7. 407 Accesses	Review Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh, Hamid R Mirshahidi Journal of Hematology & Oncology 2011, 4:16 (20 April 2011) Abstract \| Full text \| PDF \| PubMed
	8. 386 Accesses	Research Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model Dan Xu, Teresa M O, Archil Shartava, Taylor C Fowles, Jianchang Yang, Louis M Fink, David C Ward, Martin C Mihm, Milton Waner, Yupo Ma Journal of Hematology & Oncology 2011, 4:54 (22 December 2011) Abstract \| Full text \| PDF \| PubMed
	9. 375 Accesses	Research R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature Ganguly Siddhartha, Patel Vijay Journal of Hematology & Oncology 2009, 2:14 (24 March 2009) Abstract \| Full text \| PDF \| PubMed
	10. 348 Accesses	Case report Ayurvedic herbal medicine and lead poisoning Krishna S Gunturu, Priyadharsini Nagarajan, Peter McPhedran, Thomas R Goodman, Michael E Hodsdon, Matthew P Strout Journal of Hematology & Oncology 2011, 4:51 (20 December 2011) Abstract \| Full text \| PDF \| PubMed
	11. 346 Accesses	Review Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy RuiRong Yuan, Andrea Kay, William J Berg, David Lebwohl Journal of Hematology & Oncology 2009, 2:45 (27 October 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	12. 342 Accesses	Research Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines Benjawan Wudtiwai, Bungorn Sripanidkulchai, Prachya Kongtawelert, Ratana Banjerdpongchai Journal of Hematology & Oncology 2011, 4:52 (21 December 2011) Abstract \| Provisional PDF \| PubMed
	13. 328 Accesses	Review Light chain (AL) amyloidosis: update on diagnosis and management Michael Rosenzweig, Heather Landau Journal of Hematology & Oncology 2011, 4:47 (18 November 2011) Abstract \| Full text \| PDF \| PubMed
	14. 316 Accesses	Review The Four types of Tregs in malignant lymphomas Jing Wang, Xiao-Yan Ke Journal of Hematology & Oncology 2011, 4:50 (9 December 2011) Abstract \| Full text \| PDF \| PubMed
	15. 301 Accesses	Review Current findings for recurring mutations in acute myeloid leukemia Shinichiro Takahashi Journal of Hematology & Oncology 2011, 4:36 (14 September 2011) Abstract \| Full text \| PDF \| PubMed
	16. 288 Accesses	Review First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib Guoqing Wei, Shamudheen Rafiyath, Delong Liu Journal of Hematology & Oncology 2010, 3:47 (26 November 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17. 274 Accesses	Research Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient Noriyoshi Iriyama, Yuta Yoshino, Bo Yuan, Akira Horikoshi, Yukio Hirabayashi, Yoshihiro Hatta, Hiroo Toyoda, Jin Takeuchi Journal of Hematology & Oncology 2012, 5:1 (24 January 2012) Abstract \| Provisional PDF \| PubMed
	18. 269 Accesses	Review Ovarian cancer immunotherapy: opportunities, progresses and challenges Bei Liu, John Nash, Carolyn Runowicz, Helen Swede, Richard Stevens, Zihai Li Journal of Hematology & Oncology 2010, 3:7 (10 February 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 265 Accesses	Review Vorinostat in solid and hematologic malignancies David Siegel, Mohamad Hussein, Chandra Belani, Francisco Robert, Evanthia Galanis, Victoria M Richon, José Garcia-Vargas, Cesar Sanz-Rodriguez, Syed Rizvi Journal of Hematology & Oncology 2009, 2:31 (27 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	20. 262 Accesses	Case report Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen Journal of Hematology & Oncology 2008, 1:26 (18 December 2008) Abstract \| Full text \| PDF \| PubMed
	21. 257 Accesses	Review From basic research to clinical development of MEK1/2 inhibitors for cancer therapy Christophe Frémin, Sylvain Meloche Journal of Hematology & Oncology 2010, 3:8 (11 February 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22. 231 Accesses	Research Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663 Pan Jian, Zhao Li, Tao Fang, Wang Jian, Zhou Zhuan, Liao Mei, Wu Yan, Ni Jian Journal of Hematology & Oncology 2011, 4:20 (25 April 2011) Abstract \| Full text \| PDF \| PubMed
	23. 234 Accesses	Review Novel agents for anti-platelet therapy Xuebin Ji, Ming Hou Journal of Hematology & Oncology 2011, 4:44 (4 November 2011) Abstract \| Full text \| PDF \| PubMed
	24. 229 Accesses	Review Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space A Oliver Sartor Journal of Hematology & Oncology 2011, 4:18 (23 April 2011) Abstract \| Full text \| PDF \| PubMed
	25. 227 Accesses	Review Unfolded protein response in cancer: the Physician's perspective Xuemei Li, Kezhong Zhang, Zihai Li Journal of Hematology & Oncology 2011, 4:8 (23 February 2011) Abstract \| Full text \| PDF \| PubMed